FORA Capital LLC Acquires New Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

FORA Capital LLC bought a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 9,619 shares of the specialty pharmaceutical company’s stock, valued at approximately $1,408,000. Other hedge funds and […]

Related Keywords

Canada ,United States ,Neenam Patil ,Ricke Winningham , ,News Ratings For Jazz Pharmaceuticals Daily ,Huntington National Bank ,Fora Capital ,Needham Company ,Securities Exchange Commission ,Archer Investment Corp ,Quarter For Jazz Pharmaceuticals ,Nasdaq ,Jazz Pharmaceuticals Stock Performance ,Insider Transactions At Jazz Pharmaceuticals ,Jazz Pharmaceuticals ,Jazz Pharmaceuticals Profile ,Cantor Fitzgerald ,Advisors Inc ,Royal Bank ,Free Report ,Wealth Management ,National Bank ,Investment Corp ,Director Rick ,Get Free Report ,Visit Holdingschannel ,Jazz Pharmaceuticals Daily ,Nasdaq Jazz ,Jazz ,Medical ,G5087110 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,